| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | -$75.8K | -2.8K | -1.63% | $27.11 | 169K | Feb 1, 2023 | Direct | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | -$37.9K | -1.4K | -1.13% | $27.11 | 122K | Feb 1, 2023 | By The Maetzold Descendants 2020 Trust | F1, F2, F4 |
| transaction | CSTL | Common Stock | Sale | -$37.9K | -1.4K | -1.25% | $27.11 | 111K | Feb 1, 2023 | By Derek Maetzold 2020 Irrevocable Trust | F1, F2, F5 |
| transaction | CSTL | Common Stock | Sale | -$18.9K | -699 | -2.79% | $27.11 | 24.4K | Feb 1, 2023 | By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk | F1, F2, F6 |
| transaction | CSTL | Common Stock | Sale | -$18.9K | -698 | -2.78% | $27.11 | 24.4K | Feb 1, 2023 | By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold | F1, F2, F7 |
| transaction | CSTL | Common Stock | Sale | -$18.9K | -698 | -2.78% | $27.11 | 24.4K | Feb 1, 2023 | By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold | F1, F2, F8 |
| transaction | CSTL | Common Stock | Sale | -$18.9K | -698 | -2.78% | $27.11 | 24.4K | Feb 1, 2023 | By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold | F1, F2, F9 |
| holding | CSTL | Common Stock | 130K | Feb 1, 2023 | By DJM Grantor Retained Annuity Trust No. 4 | F3, F10 |
| Id | Content |
|---|---|
| F1 | These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022. |
| F2 | This transaction was executed in multiple trades at prices ranging from $26.830 to $27.555, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | On June 6, 2022, the Reporting Person transferred 130,000 shares of Castle Biosciences, Inc. common stock that was previously not reported to the DJM Grantor Retained Annuity Trust No. 4 of which the Reporting Person is trustee and beneficiary. |
| F4 | Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries. |
| F5 | Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries. |
| F6 | Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary. |
| F7 | Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. |
| F8 | Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. |
| F9 | Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. |
| F10 | Held by DJM Grantor Retained Annuity Trust No. 4 of which the Reporting Person is the trustee and beneficiary. |